Disclosure Logs
- 02/12/2025
- Nitazenes
-
-
-
FOI.18750
Nitazenes
- 02/12/2025
- Urothelial cancer
-
-
-
FOI.18829
Urothelial cancer
- 02/12/2025
- Deaths in Accident and Emergency (A&E) departments
-
-
-
FOI.18784
Deaths in Accident and Emergency (A&E) departments
- 02/12/2025
- Atopic Dermatitis and Psoriasis guidelines
-
-
-
FOI.18764
Atopic Dermatitis and Psoriasis guidelines
- 02/12/2025
- Ovarian cancer
-
-
-
FOI.18751
Ovarian cancer
- 02/12/2025
- Bronglais General Hospital (BGH) Accident and Emergency (A&E) department
-
-
-
FOI.18512
Bronglais General Hospital (BGH) Accident and Emergency (A&E) department
- 02/12/2025
- Rapid Diagnostic Clinics (RDCs)
-
-
-
FOI.18809
Rapid Diagnostic Clinics (RDCs)
- 02/12/2025
- Insourcing
-
-
-
FOI.18808
Insourcing
- 02/12/2025
- Agency doctor spend
-
-
-
FOI.18766
Agency doctor spend
- 02/12/2025
- Telephone contact details
-
-
-
FOI.18747
Telephone contact details
- 02/12/2025
- Outsourced radiology reporting
-
-
-
FOI.18732
Outsourced radiology reporting
- 02/12/2025
- Wide Area Network (WAN) services
-
-
-
FOI.18810
Wide Area Network (WAN) services
- 02/12/2025
- Agency spend
-
-
-
FOI.18773
Agency spend
- 02/12/2025
- Pest control
-
-
-
FOI.18497
Pest control
- 02/12/2025
- Printing, mail rooms and digital forms
-
-
-
FOI.18709
Printing, mail rooms and digital forms
- 02/12/2025
- Endometrial cancer
-
-
-
FOI.18786
Endometrial cancer
- 02/12/2025
- Management structures
-
-
-
FOI.18708
Management structures
- 02/12/2025
- Pembrolizumab
-
-
-
FOI.18674
Pembrolizumab
- 02/12/2025
- Insourcing
-
-
-
FOI.18700
Insourcing
- 02/12/2025
- Diversity, Equity and Inclusion (DEI)
-
-
-
FOI.18673
Diversity, Equity and Inclusion (DEI)